CTO.DECTO.DEXETRA
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+10.6%
5Y CAGR+13.3%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+10.6%/yr
vs +13.7%/yr prior
5Y CAGR
+13.3%/yr
Consistent
Acceleration
-3.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.40B | +10.3% |
| 2024 | $12.15B | +13.3% |
| 2023 | $10.72B | +8.3% |
| 2022 | $9.90B | +15.5% |
| 2021 | $8.57B | +19.5% |
| 2020 | $7.18B | +12.0% |
| 2019 | $6.41B | +8.3% |
| 2018 | $5.92B | +8.0% |
| 2017 | $5.48B | +11.2% |
| 2016 | $4.93B | - |